SCHEMBL3495772

SCHEMBL3495772

O=C(O)Nc1sc2cccnc2c1Br

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 2/20 0.43
NTRK1 P04629 1/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
LMNA P02545 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
TP53 P04637 1/20 0.36
KDM4E B2RXH2 2/20 0.35
KDR P35968 1/20 0.35
CLK1 P49759 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
MAPT P10636 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MITF O75030 1/20 0.35
HDAC6 Q9UBN7 1/20 0.34
RECQL P46063 1/20 0.34
POLB P06746 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1107214 0.80 METAP1 (0.43) LIMK1KDM4ERAB9AMAPTL3MBTL1
SCHEMBL1098450 0.76 LIMK1 (0.54) LIMK1KMT2ALMNATDP1KDM4E
SCHEMBL3494100 0.76 IKBKB (0.43) LIMK1KMT2ALMNATP53KDM4E
SCHEMBL16188800 0.74 LIMK1 (0.37) LIMK1KMT2AMEN1LMNAKDM4E
Hydrochloric Acid SCHEMBL1098254 0.73 SLC40A1 (0.51) TDP1
SCHEMBL16504977 0.72 PARP1 (0.37) KMT2AMEN1LMNATDP1TP53
SCHEMBL3967344 0.72 LIMK1 (0.41) LIMK1KMT2AMEN1LMNATDP1
SCHEMBL1098273 0.72 LIMK1 (0.49) LIMK1KMT2AMEN1LMNATDP1
SCHEMBL16505680 0.71 KMT2A (0.43) KMT2AMEN1LMNAKDM4EMAPT
SCHEMBL3494660 0.70 LMNA (0.48) LIMK1KMT2AMEN1LMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10000507-B2 Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors INCYTE CORPORATION (US) 2018-06-19 US disclosed
US-20170190716-A1 FURO- AND THIENO-PYRIDINE CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE CORPORATION 2017-07-06 US disclosed
US-9556197-B2 Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors INCYTE CORPORATION (US) 2017-01-31 US disclosed
US-20150057265-A1 FURO- AND THIENO-PYRIDINE CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE CORPORATION (US) 2015-02-26 US disclosed
US-20100093777-A1 SPIRO-RING COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-04-15 US disclosed
EP-2128163-A1 SPIRO-RING COMPOUND Takeda Pharmaceutical Company Limited (JP) 2009-12-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170190716-A1 FURO- AND THIENO-PYRIDINE CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS PIM1, PIM2, PIM3 LIMK1 827/4885NTRK1 633/4885KMT2A 721/4885
US-10000507-B2 Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors PIM1, PIM2, PIM3 LIMK1 827/4885NTRK1 633/4885KMT2A 721/4885
US-20100093777-A1 SPIRO-RING COMPOUND ACACA, PC, ACACB LIMK1 1763/4885NTRK1 3982/4885KMT2A 2374/4885
US-20150057265-A1 FURO- AND THIENO-PYRIDINE CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS PIM1, PIM2, PIM3 LIMK1 827/4885NTRK1 633/4885KMT2A 721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.